Dr Reddys Laboratories

BSE : 500124 | NSE : DRREDDY

Industry : Pharmaceuticals | ISIN : INE089A01023 | FreeFloat : 75.00% | FnO : Yes | LotSize : 125


Intellectual Capital (IC)17,209.05
Net Worth (NW)19,212.40
Intrinsic Worth (IW)36,421.45
Market Cap (MC)71,487.40
Economic Value Added-502.44
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)47.25%
IC Gross Margin (EBITDA/IC)25.40%
IC Net Margin (NPT/IC)11.45%
Knowledge Turnover (Sales/IC)1.30
Market to Intrinsic Value (MC/IW)1.96

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 2,188.45Rs. 4,295.45
26 May 2022 ---- Rs. 4,304.15
-3.30     -0.08%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 4,103.47ReduceSell
KB > 50% : No50 DMA : Rs. 4,149.78
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
3858.20
4288.30
1188.10
899.10
869.30
676.50
647.20
Sep-19
C
4812.80
4866.80
1129.50
816.40
786.10
1106.80
1152.00
Dec-19
C
4397.10
4464.40
-203.80
-490.70
-505.90
-538.40
-493.00
Mar-20
C
4448.90
4522.50
1033.30
759.20
736.20
781.10
654.80
Jun-20
C
4426.50
4513.60
1216.10
923.80
900.50
594.60
672.80
Sep-20
C
4910.90
4962.10
1214.60
898.10
872.90
771.80
783.80
Dec-20
C
4941.90
5012.40
624.90
313.70
294.90
27.90
120.80
Mar-21
C
4768.20
4850.80
1153.70
844.90
815.20
557.30
554.30
Jun-21
C
4945.10
5053.00
859.00
575.10
555.80
380.40
390.90
Sep-21
C
5786.90
5992.40
1590.00
1295.90
1272.50
995.80
974.40
Dec-21
C
5338.30
5394.10
1290.00
995.80
974.20
709.30
709.80
Mar-22
C
5474.90
5596.80
583.40
290.40
258.90
97.00
143.90
* C - Consolidated, S - Standalone